These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2906452)

  • 1. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
    Farr M; Brodrick A; Bacon PA
    Rheumatol Int; 1985; 5(6):247-51. PubMed ID: 2906452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C; Taggart AJ; Juby L; Zebouni L; Bird HA
    Ann Rheum Dis; 1990 Aug; 49(8):587-90. PubMed ID: 1975737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis.
    Taggart AJ; McDermott B; Delargy M; Elborn S; Forbes J; Roberts SD; Ahnfelt NO
    Scand J Rheumatol Suppl; 1987; 64():29-36. PubMed ID: 2893450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis.
    Pirmohamed M; Coleman MD; Galvani D; Bucknall RC; Breckenridge AM; Park BK
    Br J Rheumatol; 1993 Mar; 32(3):222-6. PubMed ID: 8095423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation.
    Whiteman M; Haigh R; Tarr JM; Gooding KM; Shore AC; Winyard PG
    Ann N Y Acad Sci; 2010 Aug; 1203():146-50. PubMed ID: 20716297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between synovial fluid and plasma manganese, arginase, and nitric oxide in patients with rheumatoid arthritis.
    Sarban S; Isikan UE; Kocabey Y; Kocyigit A
    Biol Trace Elem Res; 2007 Feb; 115(2):97-106. PubMed ID: 17435254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential changes of corticotropin releasing hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA).
    Nishioka T; Kurokawa H; Takao T; Kumon Y; Nishiya K; Hashimoto K
    Endocr J; 1996 Apr; 43(2):241-7. PubMed ID: 9026271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and synovial fluid adipocytokines in patients with rheumatoid arthritis and osteoarthritis.
    Ibrahim SM; Hamdy MS; Amer N
    Egypt J Immunol; 2008; 15(1):159-70. PubMed ID: 20306680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
    Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R
    J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone concentrations in synovial fluid of patients with rheumatoid arthritis.
    Rovensky J; Kvetnansky R; Radikova Z; Imrich R; Greguska O; Vigas M; Macho L
    Clin Exp Rheumatol; 2005; 23(3):292-6. PubMed ID: 15971415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal and adrenal steroid hormones in plasma and synovial fluid of patients with rheumatoid arthritis.
    Rovensky J; Radikova Z; Imrich R; Greguska O; Vigas M; Macho L
    Endocr Regul; 2004 Dec; 38(4):143-9. PubMed ID: 15841793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and synovial fluid levels of granulocytal elastase-alpha-1-protease inhibitor complex in patients with rheumatoid arthritis.
    Kuramitsu K; Yoshida A
    Rheumatol Int; 1990; 10(2):51-6. PubMed ID: 2349434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.